Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin's Lymphoma or Hodgkin's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00240578
What this trial is testing

Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 88
Early research (Phase 1)Study completedNCT00352443
What this trial is testing

S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
SWOG Cancer Research Network 66
Early research (Phase 1)Looking for participantsNCT05432635
What this trial is testing

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin LymphomaDiffuse Large B-Cell LymphomaMantle Cell Lymphoma+5 more
City of Hope Medical Center 15
Early research (Phase 1)WithdrawnNCT05176691
What this trial is testing

HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL

Who this might be right for
CLL/SLLNHLMCL+6 more
Hutchmed
Early research (Phase 1)UnknownNCT00935597
What this trial is testing

Host Dendritic Cells in Allograft Patients

Who this might be right for
Relapsed Non-Hodgkin's LymphomaHodgkin's DiseaseMultiple Myeloma+1 more
Icahn School of Medicine at Mount Sinai 25
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Early research (Phase 1)Ended earlyNCT02663518
What this trial is testing

A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors

Who this might be right for
Hematologic MalignanciesSolid Tumor
Pfizer 249
Early research (Phase 1)Study completedNCT00098891
What this trial is testing

MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+41 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Not Yet RecruitingNCT07334574
What this trial is testing

Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL

Who this might be right for
B-cell Non-Hodgkin's Lymphoma (B-NHL)
Ruijin Hospital 20
Early research (Phase 1)Study completedNCT00598169
What this trial is testing

Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium 23
Testing effectiveness (Phase 2)Ended earlyNCT03488251
What this trial is testing

PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin Lymphoma,B CellRefractory Diffuse Large B-Cell LymphomaRelapsed Diffuse Large B-Cell Lymphoma
Molecular Templates, Inc. 8
Early research (Phase 1)Temporarily pausedNCT04746131
What this trial is testing

Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)

Who this might be right for
B-cell Non-Hodgkin's Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 90
Testing effectiveness (Phase 2)Looking for participantsNCT05338931
What this trial is testing

Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
B-cell Non Hodgkin Lymphoma
AbClon 82
Early research (Phase 1)Looking for participantsNCT07052305
What this trial is testing

NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma

Who this might be right for
Large B-cell Lymphoma
Washington University School of Medicine 24
Early research (Phase 1)Study completedNCT00005639
What this trial is testing

Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Testing effectiveness (Phase 2)Study completedNCT00117988
What this trial is testing

17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Mantle Cell Lymphoma
National Cancer Institute (NCI) 22
Very early researchUnknownNCT05444322
What this trial is testing

RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Who this might be right for
Mantle Cell LymphomaDiffuse Large B-cell LymphomaFollicular Lymphoma
He Huang 18
Testing effectiveness (Phase 2)Study completedNCT00460109
What this trial is testing

Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT01746849
What this trial is testing

Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
LeukemiaMultiple MyelomaMyelodysplastic Syndrome+1 more
Memorial Sloan Kettering Cancer Center 82
Not applicableNot Yet RecruitingNCT06879470
What this trial is testing

JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma

Who this might be right for
B-Non Hodgkin Lymphoma
He Huang 24
Next Page